Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005929 | cilium | 4 | 1 |
GO:0005930 | axoneme | 2 | 1 |
GO:0042995 | cell projection | 2 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 1 |
Related structures:
AlphaFold database: A4HQ27
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 24 | 28 | PF00656 | 0.406 |
CLV_C14_Caspase3-7 | 249 | 253 | PF00656 | 0.568 |
CLV_NRD_NRD_1 | 260 | 262 | PF00675 | 0.621 |
CLV_PCSK_KEX2_1 | 260 | 262 | PF00082 | 0.656 |
CLV_PCSK_KEX2_1 | 35 | 37 | PF00082 | 0.366 |
CLV_PCSK_KEX2_1 | 61 | 63 | PF00082 | 0.308 |
CLV_PCSK_PC1ET2_1 | 35 | 37 | PF00082 | 0.366 |
CLV_PCSK_PC1ET2_1 | 61 | 63 | PF00082 | 0.308 |
CLV_PCSK_SKI1_1 | 107 | 111 | PF00082 | 0.571 |
DOC_CKS1_1 | 201 | 206 | PF01111 | 0.601 |
DOC_MAPK_gen_1 | 60 | 69 | PF00069 | 0.400 |
DOC_MAPK_MEF2A_6 | 60 | 69 | PF00069 | 0.400 |
DOC_MAPK_NFAT4_5 | 62 | 70 | PF00069 | 0.400 |
DOC_SPAK_OSR1_1 | 138 | 142 | PF12202 | 0.308 |
DOC_USP7_UBL2_3 | 103 | 107 | PF12436 | 0.390 |
DOC_WW_Pin1_4 | 200 | 205 | PF00397 | 0.554 |
LIG_14-3-3_CanoR_1 | 158 | 168 | PF00244 | 0.344 |
LIG_14-3-3_CanoR_1 | 181 | 189 | PF00244 | 0.310 |
LIG_14-3-3_CanoR_1 | 191 | 197 | PF00244 | 0.385 |
LIG_14-3-3_CanoR_1 | 230 | 239 | PF00244 | 0.575 |
LIG_14-3-3_CanoR_1 | 244 | 250 | PF00244 | 0.562 |
LIG_BRCT_BRCA1_1 | 184 | 188 | PF00533 | 0.344 |
LIG_CtBP_PxDLS_1 | 207 | 211 | PF00389 | 0.425 |
LIG_FHA_1 | 161 | 167 | PF00498 | 0.365 |
LIG_FHA_2 | 201 | 207 | PF00498 | 0.576 |
LIG_FHA_2 | 22 | 28 | PF00498 | 0.373 |
LIG_FHA_2 | 244 | 250 | PF00498 | 0.501 |
LIG_LIR_Apic_2 | 203 | 208 | PF02991 | 0.464 |
LIG_LIR_Gen_1 | 126 | 134 | PF02991 | 0.305 |
LIG_LIR_Nem_3 | 126 | 130 | PF02991 | 0.280 |
LIG_LIR_Nem_3 | 256 | 262 | PF02991 | 0.462 |
LIG_Pex14_1 | 184 | 188 | PF04695 | 0.284 |
LIG_Pex14_2 | 100 | 104 | PF04695 | 0.308 |
LIG_PTAP_UEV_1 | 214 | 219 | PF05743 | 0.488 |
LIG_RPA_C_Fungi | 133 | 145 | PF08784 | 0.203 |
LIG_SH2_CRK | 205 | 209 | PF00017 | 0.473 |
LIG_SH2_CRK | 259 | 263 | PF00017 | 0.471 |
LIG_SH2_NCK_1 | 205 | 209 | PF00017 | 0.473 |
LIG_SH2_SRC | 205 | 208 | PF00017 | 0.455 |
LIG_SH2_STAT3 | 30 | 33 | PF00017 | 0.284 |
LIG_SH2_STAT5 | 127 | 130 | PF00017 | 0.412 |
LIG_SH2_STAT5 | 155 | 158 | PF00017 | 0.324 |
LIG_SH2_STAT5 | 30 | 33 | PF00017 | 0.231 |
LIG_SH3_2 | 215 | 220 | PF14604 | 0.569 |
LIG_SH3_3 | 198 | 204 | PF00018 | 0.539 |
LIG_SH3_3 | 209 | 215 | PF00018 | 0.516 |
LIG_SUMO_SIM_par_1 | 162 | 167 | PF11976 | 0.344 |
LIG_TYR_ITIM | 125 | 130 | PF00017 | 0.308 |
MOD_CK1_1 | 126 | 132 | PF00069 | 0.339 |
MOD_CK1_1 | 162 | 168 | PF00069 | 0.360 |
MOD_CK1_1 | 243 | 249 | PF00069 | 0.631 |
MOD_CK1_1 | 5 | 11 | PF00069 | 0.576 |
MOD_CK2_1 | 145 | 151 | PF00069 | 0.284 |
MOD_CK2_1 | 243 | 249 | PF00069 | 0.589 |
MOD_GlcNHglycan | 62 | 65 | PF01048 | 0.400 |
MOD_GlcNHglycan | 7 | 10 | PF01048 | 0.641 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.728 |
MOD_GSK3_1 | 129 | 136 | PF00069 | 0.335 |
MOD_N-GLC_1 | 82 | 87 | PF02516 | 0.203 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.618 |
MOD_NEK2_1 | 192 | 197 | PF00069 | 0.360 |
MOD_NEK2_1 | 240 | 245 | PF00069 | 0.494 |
MOD_NEK2_1 | 254 | 259 | PF00069 | 0.480 |
MOD_NEK2_1 | 70 | 75 | PF00069 | 0.284 |
MOD_NEK2_1 | 82 | 87 | PF00069 | 0.284 |
MOD_PIKK_1 | 230 | 236 | PF00454 | 0.555 |
MOD_PKA_1 | 60 | 66 | PF00069 | 0.344 |
MOD_PKA_2 | 235 | 241 | PF00069 | 0.497 |
MOD_PKA_2 | 243 | 249 | PF00069 | 0.534 |
MOD_Plk_1 | 176 | 182 | PF00069 | 0.360 |
MOD_Plk_1 | 83 | 89 | PF00069 | 0.401 |
MOD_Plk_4 | 123 | 129 | PF00069 | 0.360 |
MOD_Plk_4 | 235 | 241 | PF00069 | 0.534 |
MOD_ProDKin_1 | 200 | 206 | PF00069 | 0.551 |
TRG_ENDOCYTIC_2 | 127 | 130 | PF00928 | 0.308 |
TRG_ENDOCYTIC_2 | 16 | 19 | PF00928 | 0.362 |
TRG_ENDOCYTIC_2 | 259 | 262 | PF00928 | 0.469 |
TRG_ER_diArg_1 | 259 | 261 | PF00400 | 0.667 |
TRG_Pf-PMV_PEXEL_1 | 48 | 52 | PF00026 | 0.357 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P360 | Leptomonas seymouri | 77% | 100% |
A0A1X0NFH5 | Trypanosomatidae | 53% | 100% |
A0A3Q8IJR1 | Leishmania donovani | 86% | 100% |
A0A422N6F8 | Trypanosoma rangeli | 55% | 83% |
A4IDT3 | Leishmania infantum | 86% | 100% |
D0A8U1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 51% | 100% |
E9ATU5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
Q4Q0Q1 | Leishmania major | 86% | 100% |